REQUEST A DEMO
Total
USD $0.00
Search more companies

Biogen Pharma d.o.o. (Croatia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biogen Pharma d.o.o. Profile Updated: July 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Biogen Pharma d.o.o. is an enterprise in Croatia, with the main office in Zagreb. The company operates in the Pharmaceutical Preparation Manufacturing sector. Biogen Pharma d.o.o. was incorporated on August 29, 2026. Biogen Pharma d.o.o. currently employs 5 (2025) people. The company’s latest financial report indicates a net sales revenue increase of 14.42% in 2025. During that time, Biogen Pharma d.o.o.’s total assets decreased by 63.37%. The net profit margin of Biogen Pharma d.o.o. decreased by 0.78% in 2025.

Headquarters
Savska Cesta 32 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Biogen Pharma d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Biogen Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Biogen Pharma d.o.o. report to view the information.
Incorporation Date:
August 29, 2026
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biogen Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
14.42%
Total Operating Revenue
14.42%
Operating Profit
3.53%
EBITDA
2.95%
Net Profit/Loss for the Period
-5.49%
Total Assets
-63.37%
Total Equity
22.7%
Operating Profit Margin
-0.47%
Net Profit Margin
-0.78%
Return on Equity (ROE)
-5.51%
Quick Ratio
1.41%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?